...
首页> 外文期刊>Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >An Intention-To-Treat Analysis of Liver Transplantation for Hepatocellular Carcinoma Using Organ Procurement Transplant Network Data
【24h】

An Intention-To-Treat Analysis of Liver Transplantation for Hepatocellular Carcinoma Using Organ Procurement Transplant Network Data

机译:利用器官采购移植网络数据进行肝细胞肝移植的意向分析

获取原文
获取原文并翻译 | 示例
           

摘要

Single-center studies have shown acceptable long-term outcomes following orthotopic liver transplantation (OLT) forhepatocellular carcinoma (HCC) when tumors are within the Milan criteria. However, the overall survival and waiting listremoval rates have not been described at a national level with pooled registry data. To evaluate this, a retrospective cohort ofpatients listed for OLT with a diagnosis of HCC between January 1998 and March 2006 was identified from Organ ProcurementTransplant Network data. Analysis was performed from the time of listing. Adjusted Cox models were used to assess therelative effect of potential confounders on removal from the waiting list as well as survival from the time of wait listing. A totalof 4482 patients with HCC were placed on the liver waiting list during the study peridd. Of these, 65% underwenttransplantation, and 18% were removed from the list because of tumor progression or death. The overall 1- and 5-yearintent-to-treat survival for all patients listed was 81% and 51%, respectively. The 1- and 5-year survival was 89% and 61% forthose listed with tumors meeting the Milan criteria versus 70% and 32% for those exceeding the Milan criteria (P < 0.0001).On multivariate analysis, advanced liver failure manifested by Child-Pugh class B or C increased the risk of death, while age <55 years, meeting the Milan criteria, and obtaining a liver transplant were associated with better survival. The current criteriafor liver transplantation of candidates with HCC lead to acceptable 5-year survival while limiting the dropout rate.
机译:单中心研究显示,当肿瘤在米兰标准范围内时,原位肝移植(OLT)治疗肝细胞癌(HCC)后可以接受长期可接受的结果。但是,尚未在国家层面使用汇总的注册表数据描述总体生存率和等待清单清除率。为了评估这一点,从器官采购移植网络数据中鉴定了1998年1月至2006年3月间OLT诊断为HCC的患者回顾性队列。从上市时间开始进行分析。调整后的Cox模型用于评估潜在混杂因素对从候补名单中删除以及从候补名单开始生存的相对影响。在研究期间,共有4482例HCC患者被列入肝候诊名单。其中,有65%进行了移植,并且由于肿瘤的进展或死亡而从名单中删除了18%。所列所有患者的1年和5年意向治疗总生存率分别为81%和51%。符合米兰标准的肿瘤的1年和5年生存率分别为89%和61%,而超出米兰标准的肿瘤则为70%和32%(P <0.0001)。在多变量分析中,Child表现为晚期肝衰竭-Pugh B级或C级增加了死亡风险,而年龄小于55岁,符合Milan标准并获得肝移植与更好的生存率相关。当前的肝癌候选者肝移植标准可以接受可接受的5年生存率,同时限制辍学率。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号